Biogen Idec (BIIB) Submits BLA to FDA for rFIXFc Marketing Approval

Go back to Biogen Idec (BIIB) Submits BLA to FDA for rFIXFc Marketing Approval
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 208.87 +4.98 (2.44%)
Previous Close $203.89    52 Week High $333.65 
Open $203.52    52 Week Low $223.02 
Day High $209.22    P/E 26.74 
Day Low $201.00    EPS $7.81 
Volume 789,029